Search result for 'bain capital'

Manappuram Finance shares jumped nearly 8% after Bain Capital launched a Rs 5,764 crore open offer to acquire a 26% stake in the gold loan financier. The stock hit a 52-week high during the day.

Bain Capital launches Rs 5,764 crore open offer to acquire 26% stake in Manappuram Finance, boosting its stake to 41.7% on a fully diluted basis.

Bain Capital will acquire an 18% stake in gold loan financier Manappuram Finance for Rs 4,385 crore, making it one of the company's promoters and providing joint control.

Three firms, including Alpha Wave Global, Blackstone, and Bain Capital, are vying to acquire a minority stake in India's largest snack and sweets company, Haldiram Snacks Food.

Macrotech Developers has acquired 45 acres in Sohna, Gurugram to build a warehousing park for Rs 110 crore, marking its entry into the Delhi-NCR market.

Macrotech Developers, a leading real estate firm, acquired Bain Capital's stake in three industrial and logistics park entities for Rs 307 crore to enhance rental income.

Macrotech Developers has acquired Bain Capital's stake in three industrial and logistics park entities for Rs 307 crore, enhancing its rental income. The move is part of the company's strategy to...

Macrotech Developers has acquired Opexefi Services and One Box Warehouse for nearly Rs 100 crore, boosting its industrial & warehousing park development business. The acquisition is part of the...

Emcure Pharmaceuticals IPO received 67.87 times subscription on the final day, with strong institutional interest. The IPO comprises a fresh issue and an offer for sale (OFS).

Emcure Pharmaceuticals's IPO received 4.98 times subscription on Day 2, driven by strong institutional investor interest. The issue, priced at Rs 960-1,008 per share, will close on July 5.

Emcure Pharmaceuticals' IPO was fully subscribed on Day 1, with strong participation from institutional investors. The IPO received bids for 1,80,25,840 shares against 1,37,03,538 shares on offer.

Emcure Pharmaceuticals, backed by Bain Capital, has raised Rs 583 crore from anchor investors ahead of its IPO. The IPO opens for subscription on July 3 and closes on July 5.

Emcure Pharmaceuticals, backed by Bain Capital, is set to launch its Rs 1,952 crore IPO on July 3. The IPO comprises a fresh issue and an Offer For Sale (OFS) by promoters and existing shareholders.

Emcure Pharmaceuticals, backed by Bain Capital, has fixed the price band for its Rs 1,952-crore IPO at Rs 960-1,008 per share. The IPO will open for subscription on July 3 and close on July 5.

Piramal Natural Resources, India Resurgence Fund, and others exit Archean Chemical Industries, selling their 10% stake for Rs 822 crore through open market transactions.

Emcure Pharmaceuticals, backed by Bain Capital, will launch its IPO on July 3. The IPO comprises a fresh issue of Rs 800 crore and an OFS by promoters and existing shareholders. The shares are...

Ola Electric and Emcure Pharmaceuticals have received Sebi's approval for IPOs, paving the way for fundraising through public offerings. Read about the details of both offerings.

Bain Capital and BNP Paribas have divested a combined 3.54% stake in L&T Finance for Rs 1,504 crore through open market transactions. Larsen & Toubro Ltd increased its stakeholding in L&T Finance...

Private equity and venture capital investments declined 35% to USD 4.4 billion in April, with global uncertainties and Indian elections impacting activity.

Emcure Pharmaceuticals, backed by Bain Capital, has filed fresh IPO papers with Sebi to raise funds. The IPO comprises a fresh issuance of equity shares and an OFS by promoters and existing...